Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2003Biology of Blood and Marrow TransplantationOpen Access

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

View Full Paper
Ask AI
Bookmark
Share

Authors

VRVoravit RatanatharathornWayne State UniversityLALois AyashWayne State UniversityCRC. ReynoldsUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ratanatharathorn et al. (2003) studied this question.

synapsesocial.com/papers/6a741b038cee7e0fe6a8cfc7https://doi.org/10.1016/s1083-8791(03)00216-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study2000 · 228 citations
  2. 2Enhanced activation of B cells in a granulocyte colony‐stimulating factor‐mobilized peripheral blood stem cell graft2001 · 22 citations
  3. 3IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab1999 · 251 citations
  4. 4Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment2002 · 56 citations
  5. 5Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease2001 · 141 citations